期刊文献+

补肾活血化痰法对拟血管性痴呆小鼠脑组织病理形态学及谷氨酸含量的影响 被引量:6

Effects of invigorating kidney, promoting blood and dissipating phlegm on the pathomorphology and Glu content of brain tissues of mice with analog vascular dementia
原文传递
导出
摘要 目的观察补肾活血化痰法对拟血管性痴呆小鼠脑组织病理形态学及谷氨酸(Glu)含量的影响,进而探讨其作用机制。方法制作脑部缺血再灌注拟血管性痴呆小鼠模型。术后第15天对各组小鼠脑组织进行病理形态学观察并检测Glu含量。结果补肾活血化痰组海马CA1区细胞线较清晰,细胞排列紧密,数量明显增多;且该组小鼠脑组织内Glu含量明显降低。结论补肾活血化痰法能抑制小鼠缺血脑组织中Glu的释放,降低其兴奋性,从而保护神经元。这可能是补肾活血化痰法治疗血管性痴呆的作用机制之一。 Objective To observe the effects of invigorating kidney, promoting blood and dissipating phlegm on the pathomorphology and Glu content of brain tissues of mice with analog vascular dementia, and to further explore the action mechanism of this method. Methods The model mice with analog vascular dementia were made by ischemia-reperfusion in the brain. 15 days after the operation, the pathomorphology was observed and Glu content in the brain tissue of mice in all groups was detected. Results In the invigorating kidney, promoting blood and dissipating phlegm group, the cell lines in CA1 area of hippocampus were relatively clear, the arrangement of cells was relatively compact and the amount of cells increased obviously. Glu content in the brain tissue obviously lowered. Conclusions Method of invigorating kidney, promoting blood and dissipating phlegm is able to protect neurons through inhibiting the release of Glu in the brain tissues of mice, thus lowering its excitotoxicity. It may be part action mechanism of this method to treat vascular dementia.
出处 《国际中医中药杂志》 2007年第1期11-14,共4页 International Journal of Traditional Chinese Medicine
基金 河北省科技开发资助项目(04276101D-70)
关键词 血管性痴呆 补肾活血化痰法 病理形态学 谷氨酸 Vascular dementia Iinvigorating kidney Promoting blood Dissipating phlegm Pathomorphology: Glu
  • 相关文献

参考文献4

二级参考文献12

  • 1李巍,张世仪,赵惠敏,严徽瑾.小鼠脑缺血性学习记忆障碍模型的建立[J].基础医学与临床,1995,15(6):46-49. 被引量:53
  • 2李巍,严徽瑾,赵慧敏.脑缺血再灌对小鼠学习记忆的影响及药物防护[J].中国康复医学杂志,1995,10(2):67-69. 被引量:35
  • 3Chen BM, Xia LM, Zhao RQ. Determination of N^G, N^G - dimethy-larginine in human plasma by high- performance liquid chromatography[J ]. Journal of chromatography B, 1997,692:467.
  • 4Iversen L, Mulvihill E, Haldeaxum B, et al. Changes in metabotropic glutamate receptor mRNA levels following global incbemia: increase of a putative presymaptlc subtype(mGluR4 ) in highly Vulmerable rat brain areas[J ]. J Neurochem, 1994,63(2) :625.
  • 5Pellegrlni - Giampietro DE, Cortex JA, Bennett MVL, et al. The GluR2 (Glu- B) hypothesis: Ca^+ -permeabie AMPA receptors in neurological disorders[J ]. Trends Neurosci, 1997,20 (10) : 464.
  • 6Muir KW, Lees KR, Clinical experience with excitatory amino acid antagonist drugs[ J ]. Stroke, 1995,26 (3) : 502.
  • 7Rogawski MA. The NMDA receptor, NMDA antagonists and epilepsy therapy[J ]. Drugs, 1992,44 (3) : 279.
  • 8胡国渊 见:陈维洲 芮耀诚 主编.脑血管意外和兴奋毒性[A].见:陈维洲,芮耀诚,主编.脑血管疾病基础与临床研究[C].济南:山东科技出版社,1993.12—25.
  • 9黄红莉,陈保健,周昊.血管性痴呆[J].基础医学与临床,1998,18(5):26-30. 被引量:28
  • 10郭起浩.血管性痴呆[J].临床精神医学杂志,1998,8(5):288-290. 被引量:12

共引文献60

同被引文献117

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部